Clinical Trial Update: Carotid Atherosclerosis: MEtformin for Insulin ResistAnce Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating metformin for insulin resistance in patients with coronary artery disease. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Professor Naveed Sattar | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED